Article Information
- Received November 7, 2011
- Accepted December 6, 2011
- First published February 1, 2012.
- Version of record published February 1, 2012.
Author Information
Author contributions
Author contributions: M.S.M., P.J.W., T.M.D., R.M.C., and A.B.W. designed research; M.S.M., P.J.W., T.T., N.S., R.M.C., and A.B.W. performed research; T.M.D. and A.B.W. contributed unpublished reagents/analytic tools; M.S.M., P.J.W., D.G.S., R.M.C., and A.B.W. analyzed data; D.G.S., R.M.C., and A.B.W. wrote the paper.
↵*M.S.M. and P.J.W. contributed equally to this work.
Disclosures
- Received November 7, 2011.
- Accepted December 6, 2011.
This work was supported by the Michael J. Fox Foundation for Parkinson's Research, the American Parkinson's Disease Association, National Institutes of Health Grant R01-NS064934, UAB Neuroscience Core Center Grant NS047466, and the benevolence of John A. and Ruth R. Jurenko. M.S.M. is supported by NIH/NINDS Grant T32 NS061788. We thank Dario Alessi for L2in1 compound; Bassel Sawaya for purified human microglia cells; and Heather Melrose and Matthew Farrer for LRRK2 knock-out mice.
- Correspondence should be addressed to Andrew B. West, 1719 6th Avenue S, University of Alabama at Birmingham, Birmingham, AL 35226. abwest{at}uab.edu